Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Megacins
Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial.
Ticagrelor monotherapy in patients with diabetes mellitus undergoing percutaneous coronary interventions: insights from the TWILIGHT trial. Cardiovasc Res. 2020 06 01; 116(7):e70-e72.
View in:
PubMed
subject areas
Aged
Aged
Coronary Artery Disease
Coronary Artery Disease
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 2
Drug-Eluting Stents
Drug-Eluting Stents
Female
Female
Hemorrhage
Hemorrhage
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Purinergic P2Y Receptor Antagonists
Purinergic P2Y Receptor Antagonists
Randomized Controlled Trials as Topic
Randomized Controlled Trials as Topic
Risk Assessment
Risk Assessment
Risk Factors
Risk Factors
Treatment Outcome
Treatment Outcome
authors with profiles
Usman Baber